Research programme: HIV neutralising antibodies - Serum Institute of India/IAVI
Alternative Names: bNAbsLatest Information Update: 28 Nov 2022
At a glance
- Originator International AIDS Vaccine Initiative; Serum Institute of India
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action HIV antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Nov 2022 No recent reports of development identified for preclinical development in HIV-infections in India (Parenteral)
- 28 Nov 2022 No recent reports of development identified for preclinical development in HIV-infections in USA (Parenteral)
- 22 Oct 2018 IAVI and Serum Institute of India enter into strategic partnership for development of monoclonal antibodies for HIV infections